CON-HM0P34-100μg / 询价
CON-HM0P34-100μg x 5 / 询价
CON-HM0P34-100μg x 10 / 询价
表达区间及表达系统(Source)
|
Recombinant FITC-equivalent VLP Control is expressed from HEK293 |
波长(Wavelength)
|
Excitation Wavelength: 490 nm Emission Wavelength: 520 nm |
纯度(Purity)
|
> 95% as determined by HPLC |
内毒素(Endotoxin)
|
Less than 1EU per μg by the LAL method. |
制剂(Formulation)
|
Supplied as 0.22 μm filtered solution in PBS, 150mM L-Arginine (pH 7.4). |
存储(Storage)
|
Valid for 12 months from date of receipt when stored at -80°C. |
Recombinant FITC-equivalent VLP Control is expressed from HEK293
Excitation Wavelength: 490 nm
Emission Wavelength: 520 nm
> 95% as determined by HPLC
Less than 1EU per μg by the LAL method.
Supplied as 0.22 μm filtered solution in PBS, 150mM L-Arginine (pH 7.4).
Valid for 12 months from date of receipt when stored at -80°C.
Recommend to aliquot the protein into smaller quantities for optimal storage. Please minimize freeze-thaw cycles.
VLPs are formed by spontaneous interaction between one or more viral structural capsid proteins to form the final structure. VLPs are structurally and visually similar to live viruses but lack either a complete virus genome or lack the entire virus genome[1]. The FITC-equivalent VLP control refers to a pure viral protein particle structure that contains a fluorescent group but without the displayed proteins, which can be used as control for the activity assay of fluorescently labeled VLP display proteins.
VLP; VLP Control
[1] Nooraei S, Bahrulolum H, Hoseini ZS, Katalani C, Hajizade A, Easton AJ, Ahmadian G. Virus-like particles: preparation, immunogenicity and their roles as nanovaccines and drug nanocarriers. J Nanobiotechnology. 2021 Feb 25;19(1):59.
CON-HM0P34-100μg / 询价
CON-HM0P34-100μg x 5 / 询价
CON-HM0P34-100μg x 10 / 询价
货号* | 规格* | 名称 | 数量* | |
---|---|---|---|---|
货号* | 名称 | 批号* | |
---|---|---|---|